SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-23-004328
Filing Date
2023-03-24
Accepted
2023-03-24 16:51:43
Documents
14
Period of Report
2023-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K maia-8k_20230324.htm   iXBRL 8-K 45892
2 EX-99.1 maia-ex991_57.htm EX-99.1 32395
3 GRAPHIC gh0ze0hknawh000001.jpg GRAPHIC 22319
  Complete submission text file 0001564590-23-004328.txt   249919

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA maia-20230324.xsd EX-101.SCH 5585
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE maia-20230324_lab.xml EX-101.LAB 20210
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE maia-20230324_pre.xml EX-101.PRE 11988
8 EXTRACTED XBRL INSTANCE DOCUMENT maia-8k_20230324_htm.xml XML 3699
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 23760544
SIC: 2834 Pharmaceutical Preparations